PH12013501424B1 - Anti-cd38 antibodies - Google Patents
Anti-cd38 antibodiesInfo
- Publication number
- PH12013501424B1 PH12013501424B1 PH1/2013/501424A PH12013501424A PH12013501424B1 PH 12013501424 B1 PH12013501424 B1 PH 12013501424B1 PH 12013501424 A PH12013501424 A PH 12013501424A PH 12013501424 B1 PH12013501424 B1 PH 12013501424B1
- Authority
- PH
- Philippines
- Prior art keywords
- antibodies
- disclosed
- cynomolgus
- bind
- therapeutic
- Prior art date
Links
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 abstract 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 102000052645 human CD38 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061428699P | 2010-12-30 | 2010-12-30 | |
| US201161470406P | 2011-03-31 | 2011-03-31 | |
| PCT/US2011/068235 WO2012092612A1 (en) | 2010-12-30 | 2011-12-30 | Anti-cd38 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12013501424A1 PH12013501424A1 (en) | 2013-09-09 |
| PH12013501424B1 true PH12013501424B1 (en) | 2020-09-25 |
Family
ID=95291001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2013/501424A PH12013501424B1 (en) | 2010-12-30 | 2011-12-30 | Anti-cd38 antibodies |
Country Status (1)
| Country | Link |
|---|---|
| PH (1) | PH12013501424B1 (en) |
-
2011
- 2011-12-30 PH PH1/2013/501424A patent/PH12013501424B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12013501424A1 (en) | 2013-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020012426A (en) | Anti-cd38 antibodies. | |
| MX350200B (en) | Human antibodies and antibody-drug conjugates against cd74. | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| PH12014501108A1 (en) | Anti-il-36r antibodies | |
| PH12012501793B1 (en) | Monoclonal antibodies against c-met | |
| PH12013500810B1 (en) | Anti-il-23 antibodies | |
| MX347734B (en) | S100a4 antibodies and therapeutic uses thereof. | |
| MY155950A (en) | Anti-cd40 antibodies | |
| SG184310A1 (en) | Antibodies that bind human cd27 and uses thereof | |
| AU2010233994A8 (en) | Bispecific anti-ErbB-3/anti-c-Met antibodies | |
| WO2012065022A3 (en) | Spiro-oxindole mdm2 antagonists | |
| MX347893B (en) | Human antibody drug conjugates against tissue factor. | |
| MX346375B (en) | Spiro-oxindole mdm2 antagonists. | |
| MX336682B (en) | Antibodies against human csf-1r and uses thereof. | |
| MX2013012572A (en) | Anti-cd40 antibodies and methods of use. | |
| TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
| MX349004B (en) | New compounds. | |
| PH12013501424B1 (en) | Anti-cd38 antibodies | |
| TN2013000265A1 (en) | Anti-cd38 antibodies | |
| TN2013000186A1 (en) | Anti-il-23 antibodies | |
| TN2013000202A1 (en) | Spiro-oxindole mdm2 antagonists |